AKR-201

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAKR-201
Drug Alias Nametetrac (Beartown/AkaRx/MGI)tetraiodothyroacetic acid (Beartown/AkaRx/MGI)Tetractetraiodothyroacetic acidtetraiodothyroacetic acid (Beartown/AkaRx/Eisai) +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid hormone receptor agonists
TargetsThyroid hormone receptor
Therapy Area/IndicationsHypothyroidism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBeartown Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeartown Pharma IncAkarx IncEisai Co Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsHypothyroidism

Other Information

ATC CodeN/A
Related LinksN/A